Blood purification for children with early severe sepsis
Part of Infections clinical trials.
This trial studies a blood-cleaning treatment in children with early, serious sepsis to see if it helps organs recover. It’s meant for children who are very sick soon after sepsis starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 29 days old and 18 years old.
- Sepsis must be diagnosed within the last 48 hours.
- Your child has signs of serious illness affecting more than one organ, poor blood flow to tissues, or septic shock.
- You (or a legal decision-maker) can give informed consent for the study.
- Your child should not have conditions that make the treatment unsafe (like chronic dialysis for end-stage kidney disease, uncontrolled bleeding, or severe heparin allergy).
- Your child has not been on certain cancer-fighting or immune-suppressing medicines in the last 14 days, and is not on another research drug/device trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This study looks at children with sepsis to see how outcomes differ between those who receive a specific blood-cleansing treatment (CBP) and those who do not. Results may help clinicians choose treatments that lead to better recovery in sick children.
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
This trial tests whether a blood-filtering device can help people with septic shock by removing harmful substances from the blood. It is for adults who have been diagnosed with septic shock within the last 24 hours.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.